search
Back to results

Feasibility of a Multimodal Intervention Program to Optimize Treatment Outcomes in Ulcerative Colitis (OPTIMIZE-UC)

Primary Purpose

Ulcerative Colitis

Status
Not yet recruiting
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Multimodal intervention program
Sponsored by
Radboud University Medical Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Ulcerative Colitis

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Age ≥ 18 years old; Diagnosis of UC confirmed by clinical, endoscopic, and/or histological evidence prior to screening as per standard criteria; Ability of subject to participate fully in all aspects of this project; Written informed consent must be obtained and documented. Exclusion Criteria: Suspicion of differential diagnosis of CD, indeterminate colitis, ischemic colitis, radiation colitis, diverticular disease associated with colitis, or microscopic colitis; Serious underlying disease other than UC that in the opinion of the investigator may interfere with the subject's ability to participate fully in the study or would compromise subject safety (such as history of malignancies, major neurological disorders, certain orthopedic impairments or any unstable, uncontrolled or severe systemic medical disorder); History of alcohol or drug abuse that in the opinion of the investigator may interfere with the subject's ability to comply with the study procedures; History of psychiatric disorders that in the opinion of the investigator may interfere with the subject's ability to comply with the study procedures; If female, the subject is pregnant or lactating (< 1 year) or intending to become pregnant; Immobilized patients who are not able to complete exercise intervention; Illiteracy (disability to read and understand Dutch).

Sites / Locations

  • Dorien Oomkens

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Patients with ulcerative colitis

Arm Description

Patients participate in multimodal intervention

Outcomes

Primary Outcome Measures

Accrural
The percentage of approached, eligible participants that are included in the study.
Attrition
The percentage of participants who stopped the program prematurely.
Adherence to exercise program
Frequency of followed trainings
Adherence to daily exercise goals
SQUASH questionnaire
Satisfaction
Measured using a patient satisfaction questionnaire
Safety
Measured by the number of adverse events occurring during the program

Secondary Outcome Measures

Change in Oxygen Consumption (VO2 max)
Indication of physical fitness
Change in 1 repitition measures
Indication of muscle strength
Change in body weight
Measured in kilograms
Change in fat-free mass
Measured with bioelectrical impedance analysis (BIA)
Change in nutritional status
Measured with Patient Generated Subjective Global Assessment (PG-SGA)
Change in mental health
Hospital Anxiety and Depression scale (HADS questionnaire)
Change in Work Productivity and Activity Impairment
Work Productivity and Activity Impairment Questionnaire (including WPAI-GH)
Change in 36-Item Short Form Health Survey (SF-36) score
Quality of life
Change in EuroQoL (EQ-5D-5L) score
Quality of life
Change in Inflammatory Bowel Disease Questionnaire score
Disease-related quality of life

Full Information

First Posted
January 20, 2023
Last Updated
September 7, 2023
Sponsor
Radboud University Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT05743153
Brief Title
Feasibility of a Multimodal Intervention Program to Optimize Treatment Outcomes in Ulcerative Colitis
Acronym
OPTIMIZE-UC
Official Title
OPTIMIZE-UC: Feasibility of a Multimodal Intervention Program to Optimize Treatment Outcomes in Ulcerative Colitis: A Prospective Pilot Study
Study Type
Interventional

2. Study Status

Record Verification Date
January 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
October 1, 2023 (Anticipated)
Primary Completion Date
October 1, 2024 (Anticipated)
Study Completion Date
October 1, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Radboud University Medical Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This is a prospective, interventional pilot study to assess the feasibility and optimal timing of a multimodal intervention program in Ulcerative Colitis (UC) patients with active disease as well as in patients in remission. Secondly, to demonstrate the effects of a multimodal intervention program on individual patients level and therapy outcomes.
Detailed Description
Rationale: Despite considerable advances in the knowledge of UC, and a variation of treatment options, UC still impacts patients' ability to lead a normal life. Clearly, there is an unmet need to improve treatment outcomes. Prehabilitation programs in surgery have shown that the amount of complications is closely related to preoperative physical fitness, nutritional status and psychological well-being. IBD patients often search for self-management strategies to manage their symptoms, however, research focussing on a multimodal intervention approach in parallel to starting new IBD treatment is lacking. Given the potential benefits of intervention programs, limitations of current treatments in terms of improving quality of life and patients' desire for self-management options, we believe that exploring the results of a multimodal intervention program in patients with UC is of high relevance. Objective/study design: This is a prospective, interventional pilot study to assess the feasibility and optimal timing of a multimodal intervention program in UC patients. Secondly, to demonstrate the effects of a multimodal intervention program on individual patients level and therapy outcomes. Study population: Patients ≥ 18 years old, with UC. Intervention: Multimodal intervention program including an exercise program, nutritional intervention and psychological evaluation. Main study parameters/endpoints: This study assesses the feasibility of a multimodal intervention program. Secondary, assesses the effect on: Individual patients' level, i.e. physical fitness, nutritional status, mental health, quality of life and work productivity and activity impairment. Therapy outcomes, e.g. adherence, number and severity of (S)AEs, corticosteroid use, biochemical and clinical response/remission rates and patient reported outcomes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ulcerative Colitis

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
30 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Patients with ulcerative colitis
Arm Type
Experimental
Arm Description
Patients participate in multimodal intervention
Intervention Type
Behavioral
Intervention Name(s)
Multimodal intervention program
Intervention Description
Exercise intervention: combined endurance and resistance training three times a week using workout video's which patients can do at home. Advice to exercise at low-intensity for at least 30 minutes per day. Nutritional intervention: Patients are advised to aim for optimal energy and protein intake (by registered dietician) and to avoid red meat, processed foods and sweetened drinks. Aiming for a mainly plant based diet. Psychological intervention: screening for psychological risk factors and if present, patients are referred to a psychologist for psychological support.
Primary Outcome Measure Information:
Title
Accrural
Description
The percentage of approached, eligible participants that are included in the study.
Time Frame
24 weeks
Title
Attrition
Description
The percentage of participants who stopped the program prematurely.
Time Frame
24 weeks
Title
Adherence to exercise program
Description
Frequency of followed trainings
Time Frame
24 weeks
Title
Adherence to daily exercise goals
Description
SQUASH questionnaire
Time Frame
24 weeks
Title
Satisfaction
Description
Measured using a patient satisfaction questionnaire
Time Frame
24 weeks
Title
Safety
Description
Measured by the number of adverse events occurring during the program
Time Frame
24 weeks
Secondary Outcome Measure Information:
Title
Change in Oxygen Consumption (VO2 max)
Description
Indication of physical fitness
Time Frame
1 year
Title
Change in 1 repitition measures
Description
Indication of muscle strength
Time Frame
1 year
Title
Change in body weight
Description
Measured in kilograms
Time Frame
1 year
Title
Change in fat-free mass
Description
Measured with bioelectrical impedance analysis (BIA)
Time Frame
1 year
Title
Change in nutritional status
Description
Measured with Patient Generated Subjective Global Assessment (PG-SGA)
Time Frame
1 year
Title
Change in mental health
Description
Hospital Anxiety and Depression scale (HADS questionnaire)
Time Frame
1 year
Title
Change in Work Productivity and Activity Impairment
Description
Work Productivity and Activity Impairment Questionnaire (including WPAI-GH)
Time Frame
1 year
Title
Change in 36-Item Short Form Health Survey (SF-36) score
Description
Quality of life
Time Frame
1 year
Title
Change in EuroQoL (EQ-5D-5L) score
Description
Quality of life
Time Frame
1 year
Title
Change in Inflammatory Bowel Disease Questionnaire score
Description
Disease-related quality of life
Time Frame
1 year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age ≥ 18 years old; Diagnosis of UC confirmed by clinical, endoscopic, and/or histological evidence prior to screening as per standard criteria; Ability of subject to participate fully in all aspects of this project; Written informed consent must be obtained and documented. Exclusion Criteria: Suspicion of differential diagnosis of CD, indeterminate colitis, ischemic colitis, radiation colitis, diverticular disease associated with colitis, or microscopic colitis; Serious underlying disease other than UC that in the opinion of the investigator may interfere with the subject's ability to participate fully in the study or would compromise subject safety (such as history of malignancies, major neurological disorders, certain orthopedic impairments or any unstable, uncontrolled or severe systemic medical disorder); History of alcohol or drug abuse that in the opinion of the investigator may interfere with the subject's ability to comply with the study procedures; History of psychiatric disorders that in the opinion of the investigator may interfere with the subject's ability to comply with the study procedures; If female, the subject is pregnant or lactating (< 1 year) or intending to become pregnant; Immobilized patients who are not able to complete exercise intervention; Illiteracy (disability to read and understand Dutch).
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Dorien Oomkens
Phone
+31650084590
Email
dorien.oomkens@radboudumc.nl
Facility Information:
Facility Name
Dorien Oomkens
City
Nijmegen
ZIP/Postal Code
6525GA
Country
Netherlands
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Dorien Oomkens, MD
Phone
+31650084590
Email
dorien.oomkens@radboudumc.nl
First Name & Middle Initial & Last Name & Degree
Marjolijn Duijvestein, MD PhD
First Name & Middle Initial & Last Name & Degree
Dorien Oomkens, MD

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Feasibility of a Multimodal Intervention Program to Optimize Treatment Outcomes in Ulcerative Colitis

We'll reach out to this number within 24 hrs